Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir

Clinical trial NCT03374358 · COMPLETED

Trial details

NCT number: NCT03374358
Sponsor: Helsinki University Central Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Seropositivity Metabolic Syndrome Fatty Liver

Start date: 2018-01-10
Primary completion: 2019-11-02
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.